Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
dry eye disease
Pharma
J&J unloads eye drops line to acquisitive Bausch + Lomb
The J&J eye drop acquisition comes days after Bausch + Lomb struck another deal to buy dry eye med Xiidra from Novartis.
Angus Liu
Jul 6, 2023 10:29am
Bausch + Lomb launches new social-media-led campaign
Jul 5, 2023 9:10am
Bausch + Lomb scoops up Novartis' dry eye med Xiidra for $2.5B
Jun 30, 2023 10:05am
Bausch + Lomb's dry eye disease treatment Miebo nabs FDA nod
May 19, 2023 10:40am
Novartis targets Xiidra in eye disease asset sale: Bloomberg
Mar 14, 2023 10:22am
Kala buys time by selling eye disease drugs to Alcon for $60M
May 24, 2022 10:35am